BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24981199)

  • 1. Little evidence for association between the TGFBR1*6A variant and colorectal cancer: a family-based association study on non-syndromic family members from Australia and Spain.
    Ross JP; Lockett LJ; Tabor B; Saunders IW; Young GP; Macrae F; Blanco I; Capella G; Brown GS; Lockett TJ; Hannan GN
    BMC Cancer; 2014 Jul; 14():475. PubMed ID: 24981199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
    Castillejo A; Mata-Balaguer T; Montenegro P; Ochoa E; Lázaro R; Martínez-Cantó A; Castillejo MI; Guarinos C; Barberá VM; Guillén-Ponce C; Carrato A; Soto JL
    BMC Cancer; 2009 Jun; 9():193. PubMed ID: 19538729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.
    Skoglund Lundin J; Vandrovcova J; Song B; Zhou X; Zelada-Hedman M; Werelius B; Houlston RS; Lindblom A
    Br J Cancer; 2009 May; 100(10):1674-9. PubMed ID: 19401691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis.
    Zhang X; Wu L; Sheng Y; Zhou W; Huang Z; Qu J; Gao G; Cai D; Zhang M
    Mol Biol Rep; 2012 Mar; 39(3):2567-74. PubMed ID: 21858550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFBR1*6A polymorphism in sporadic and familial colorectal Carcinoma: a case-control study and systematic literature review.
    Ibrahim T; Yazbeck C; Maalouly G; Baz M; Haddad F; Sabbagh C; Chahine G
    J Gastrointest Cancer; 2014 Dec; 45(4):441-7. PubMed ID: 24880985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancer.
    Martinez-Canto A; Castillejo A; Mata-Balaguer T; Castillejo MI; Hernandez-Illan E; Irles E; Barbera VM; Egoavil C; Guarinos C; Alenda C; Ochoa E; Lazaro R; Fajardo S; Lacueva J; Calpena R; Soto JL
    PLoS One; 2012; 7(1):e30812. PubMed ID: 22292045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
    Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
    Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study.
    Castillejo A; Mata-Balaguer T; Guarinos C; Castillejo MI; Martínez-Cantó A; Barberá VM; Montenegro P; Ochoa E; Lázaro R; Guillén-Ponce C; Carrato A; Soto JL
    BMC Cancer; 2009 Nov; 9():406. PubMed ID: 19930569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia?
    Daley D; Morgan W; Lewis S; Willis J; Elston RC; Markowitz SD; Wiesner GL
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):892-4. PubMed ID: 17507611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
    Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
    Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic acquisition and signaling of TGFBR1*6A in cancer.
    Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
    JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer.
    Valle L; Serena-Acedo T; Liyanarachchi S; Hampel H; Comeras I; Li Z; Zeng Q; Zhang HT; Pennison MJ; Sadim M; Pasche B; Tanner SM; de la Chapelle A
    Science; 2008 Sep; 321(5894):1361-5. PubMed ID: 18703712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive assessment of variation at the transforming growth factor beta type 1 receptor locus and colorectal cancer predisposition.
    Carvajal-Carmona LG; Churchman M; Bonilla C; Walther A; Lefèvre JH; Kerr D; Dunlop M; Houlston R; Bodmer WF; Tomlinson I
    Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7858-62. PubMed ID: 20368424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Debate about TGFBR1 and the susceptibility to colorectal cancer.
    Valle L
    World J Gastrointest Oncol; 2012 Jan; 4(1):1-8. PubMed ID: 22347533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families.
    Saunders IW; Ross J; Macrae F; Young GP; Blanco I; Brohede J; Brown G; Brookes D; Lockett T; Molloy PL; Moreno V; Capella G; Hannan GN
    Eur J Hum Genet; 2012 Jan; 20(1):91-6. PubMed ID: 21829229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study.
    Hu YS; Pan Y; Li WH; Zhang Y; Li J; Ma BA
    BMC Cancer; 2010 Apr; 10():169. PubMed ID: 20429896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variations in the TGFβ signaling pathway, smoking and risk of colorectal cancer in a Chinese population.
    Zhong R; Liu L; Zou L; Sheng W; Zhu B; Xiang H; Chen W; Chen J; Rui R; Zheng X; Yin J; Duan S; Yang B; Sun J; Lou J; Liu L; Xie D; Xu Y; Nie S; Miao X
    Carcinogenesis; 2013 Apr; 34(4):936-42. PubMed ID: 23275154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.
    Castillejo A; Rothman N; Murta-Nascimento C; Malats N; García-Closas M; Gómez-Martínez A; Lloreta J; Tardón A; Serra C; García-Closas R; Chanock S; Silverman DT; Dosemeci M; Kogevinas M; Carrato A; Soto JL; Real FX
    Int J Cancer; 2009 Feb; 124(3):608-13. PubMed ID: 19004027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC).
    Xicola RM; Bontu S; Doyle BJ; Rawson J; Garre P; Lee E; de la Hoya M; Bessa X; Clofent J; Bujanda L; Balaguer F; Castellví-Bel S; Alenda C; Jover R; Ruiz-Ponte C; Syngal S; Andreu M; Carracedo A; Castells A; Newcomb PA; Lindor N; Potter JD; Baron JA; Ellis NA; Caldes T; LLor X
    Carcinogenesis; 2016 Aug; 37(8):751-8. PubMed ID: 27234654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies.
    Wang YQ; Qi XW; Wang F; Jiang J; Guo QN
    PLoS One; 2012; 7(8):e42899. PubMed ID: 22905183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.